Heron Therapeutics, Inc. (HRTX) vs Tiziana Life Sciences Ltd (TLSA)
A side-by-side comparison of Heron Therapeutics, Inc. and Tiziana Life Sciences Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 2:04 PM EDT
TLSA
Tiziana Life Sciences Ltd
$1.07HealthcareDelayed quote: Oct 6, 2026, 2:02 PM EDT
Total return — HRTX vs TLSA
growth of $100 · dividends reinvested · last 8yHRTX -98.5% (-40.7%/yr)TLSA -74.3% (-15.6%/yr)TLSA compounded faster over this window
Log scale — wide-divergence pair
HRTX TLSA
HRTX vs TLSA: by the numbers
- •TLSA is the larger company ($68M vs $63M market cap).
- •Both run net losses; TLSA's is the smaller (0.00% vs -22.52% net margin).
Metrics side by side
Valuation
| Metric | HRTX | TLSA |
|---|---|---|
| P/S ratio | 0.42 | N/A |
| P/B ratio | 10.83 | 1309.30 |
Profitability
| Metric | HRTX | TLSA |
|---|---|---|
| Gross margin | 70.07% | 0.00% |
| Operating margin | -7.19% | 0.00% |
| Net margin | -22.52% | 0.00% |
| ROE | -492.89% | -35444.23% |
| ROIC | -6.79% | N/A |
Growth (annualized)
| Metric | HRTX | TLSA |
|---|---|---|
| Revenue CAGR (5Y) | 12.73% | N/A |
| Total return CAGR (5Y) | -48.61% | -5.37% |
Frequently asked
- How have HRTX and TLSA total returns compared?
- Over the past 5 years, HRTX delivered -48.61% and TLSA delivered -5.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.